AGENTS D'ARNI, COMPOSITIONS ET PROCÉDÉS D'UTILISATION CORRESPONDANTS POUR TRAITER DES MALADIES ASSOCIÉES À LA TRANSTHYRÉTINE (TTR)
- 专利权人:
- Alnylam Pharmaceuticals; Inc.
- 发明人:
- 申请号：
- EP17184486.3
- 公开号：
- EP3301177A1
- 申请日:
- 2012.11.16
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention provides RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene and methods of using such RNAi agents for treating or preventing TTR-associated diseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- AGENTS ARNI, COMPOSITIONS ET PROCEDES D'UTILISATION DE CEUX-CI POUR TRAITER DES MALADIES ASSOCIEES A LA TRANSTHYRETINE (TTR)
- RNAi agents, compositions and Methods of Use thereof for treating Diseases associated with transthyretin (TTR)
- RNAi agents, compositions and Methods of Use thereof for treating Diseases associated with transthyretin (TTR)
- Double stranded RNA interference agents, compositions and Methods of Use thereof for treating Diseases associated with transthyretin (TTR).
- RNAi agents, compositions and Methods of Use thereof for treating Diseases associated with transthyretin (TTR)
